Targeting Approaches of Nanomedicines in Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a hematological malignancy, which is commonly associated with high incidence and mortality among adult patients. The standard induction regimen for AML has been substantially unchanged over the past 40 years, for which novel nanomedicines have represented a promising...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xiao, Lin, Hai, Huang, Feng, Xie, Yuning, Wong, Ka Hong, Chen, Xiaoyu, Wu, Dongyue, Lu, Aiping, Yang, Zhijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Nanotechnology and Microtechnology in Drug Delivery Systems
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906351/
https://www.ncbi.nlm.nih.gov/pubmed/31853234
http://dx.doi.org/10.1177/1559325819887048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906351/
https://www.ncbi.nlm.nih.gov/pubmed/31853234
http://dx.doi.org/10.1177/1559325819887048

Ejemplares similares